Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
---|
12/24/1996 | US5587454 Omega conopeptide compositions |
12/24/1996 | US5587366 Compositions useful in prophylaxis and therapy of endotoxin related conditions |
12/24/1996 | US5587360 Platelet adhesion inhibitor |
12/24/1996 | US5587359 Human derived glycoprotein, biologically active factor which includes glycoprotein and pharmaceutical product |
12/24/1996 | US5587311 DNA encoding a cell membrane glycoprotein of a tick gut |
12/24/1996 | US5587310 Coagulation factor v in which 1 to 5 a3 domain exons are replaced with homologous exons of coagulation factor viii |
12/24/1996 | US5587308 Modified adeno-associated virus vector capable of expression from a novel promoter |
12/24/1996 | US5587307 FemA gene of staphylococcus epidermidis, femA protein, and vectors and microorganisms comprising the femA gene |
12/24/1996 | US5587305 Pasteurella haemolytica transformants |
12/24/1996 | US5587302 T cell growth factor |
12/24/1996 | US5587301 DNA encoding a hyaluronan receptor expressed in human umbilical vein endothelial cells |
12/24/1996 | US5587300 Method to increase regulatory molecule production |
12/24/1996 | US5587299 Isolated nucleic acid molecule coding for fibroblast activation protein alpha and uses thereof |
12/24/1996 | US5587297 Method for identification of disease-specific surface components of vascular endothelial cells |
12/24/1996 | US5587289 Isolated nucleic acid molecules which are members of the MAGE-Xp family and uses thereof |
12/24/1996 | US5587288 Regulation of exoprotein in Staphylococcus aureus |
12/24/1996 | CA1338807C Plasmid vector with pectate lyase signal sequence |
12/21/1996 | CA2169201A1 Lactic bacteria producing exopolysaccharides |
12/20/1996 | CA2152141A1 Monocyte chemoattractant protein (mcp)-1 antagonists |
12/19/1996 | WO1996041198A1 Method for the isolation of lipoprotein (a) allowing for the subsequent quantification of its mass and cholesterol content |
12/19/1996 | WO1996041196A1 Method for detection of antibody to hepatitis c virus second envelope glycoprotein |
12/19/1996 | WO1996041191A1 Methods and uses for apoptin |
12/19/1996 | WO1996041187A1 Improved hapten-peptide conjugates to detect anti-hiv-1 or anti-hiv-2 antibodies |
12/19/1996 | WO1996041179A1 Expression system for non-secretor genes |
12/19/1996 | WO1996041172A1 Functional surrogates of analytes of interest and methods of obtaining and using same |
12/19/1996 | WO1996041019A1 Use of nucleic acid ligands in flow cytometry |
12/19/1996 | WO1996041018A1 Methods, kits, and compositions for diagnosing papillomavirus infection |
12/19/1996 | WO1996041013A1 Method for screening for receptor agonists and antagonists |
12/19/1996 | WO1996041005A1 Methods for nucleic acid detection, sequencing, and cloning using exonuclease |
12/19/1996 | WO1996041004A1 Method for discovery of peptide receptor agonists |
12/19/1996 | WO1996040998A1 PCR-BASED cDNA SUBTRACTIVE CLONING METHOD |
12/19/1996 | WO1996040991A1 Enzyme linked oligonucleotide assays (elonas) |
12/19/1996 | WO1996040979A1 Methods for evaluation of antimicrobial targets |
12/19/1996 | WO1996040977A1 Origin of replication complex genes |
12/19/1996 | WO1996040973A1 Nucleic acid sequences encoding dendroides anti-freeze proteins |
12/19/1996 | WO1996040966A1 Compositions and methods of treating il-6 associated diseases |
12/19/1996 | WO1996040959A1 Cell line producing analgesic compounds for treating pain |
12/19/1996 | WO1996040958A1 Nucleic acid transporters for delivery of nucleic acids into a cell |
12/19/1996 | WO1996040957A1 Recombinant feline immunodeficiency vaccines produced in baculovirus |
12/19/1996 | WO1996040956A1 Recombinant feline immunodeficiency vaccines produced in baculovirus |
12/19/1996 | WO1996040953A1 Genetically altered feline immunodeficiency viruses and their use as an effective vaccine against feline immunodeficiency virus infection |
12/19/1996 | WO1996040951A2 Use of ovary-tissue transcriptional factors |
12/19/1996 | WO1996040949A1 Induction of male sterility in plants by expression of high levels of avidin |
12/19/1996 | WO1996040948A2 RESISTANCE TO VIRUSES AND VIROIDS IN TRANSGENIC PLANT AND ANIMAL HOSTS EXPRESSING dsRNA-BINDING PROTEIN |
12/19/1996 | WO1996040945A2 Nucleic acid respiratory syncytial virus vaccines |
12/19/1996 | WO1996040944A2 Fused soluble mhc heterodimer:peptide complexes and their uses |
12/19/1996 | WO1996040943A1 Use of gram-positive bacteria to express recombinant proteins |
12/19/1996 | WO1996040941A1 Chimeric antibodies for delivery of antigens to selected cells of the immune system |
12/19/1996 | WO1996040939A2 Expression of functional vertebrate phospholipases in yeast |
12/19/1996 | WO1996040933A1 Infectious dengue 2 virus pdk-53 as quadravalent vaccine |
12/19/1996 | WO1996040932A1 Vaccine for porcine reproductive and respiratory syndrome virus |
12/19/1996 | WO1996040931A1 Neutralizing conformational epitopes of chicken anemia virus |
12/19/1996 | WO1996040930A1 Mutants of streptococcal toxin a and methods of use |
12/19/1996 | WO1996040929A2 Transferrin receptor genes |
12/19/1996 | WO1996040928A1 Streptococcal heat shock proteins members of the hsp70 family |
12/19/1996 | WO1996040927A1 Isospora suis vaccine |
12/19/1996 | WO1996040926A2 Detection of cryptosporidium parvum |
12/19/1996 | WO1996040925A2 Regulatory elements conferring tapetum specificity |
12/19/1996 | WO1996040924A2 Cotton fiber transcriptional factors |
12/19/1996 | WO1996040923A1 Macrophage derived chemokine and chemokine analogs |
12/19/1996 | WO1996040922A1 Novel serpin derived from human hypothalamus |
12/19/1996 | WO1996040920A1 Modified hemoglobin-like compounds and methods of purifying same |
12/19/1996 | WO1996040919A1 3' utr of the human prohibitin gene |
12/19/1996 | WO1996040918A2 Novel cd40l mutein |
12/19/1996 | WO1996040917A1 NOVEL NuMA-INTERACTING PROTEINS AND METHODS FOR THEIR IDENTIFICATION |
12/19/1996 | WO1996040916A1 Icam-4 materials and methods |
12/19/1996 | WO1996040915A2 Novel ctla4/cd28 ligands and uses therefor |
12/19/1996 | WO1996040914A1 Truncated hepatocyte growth factor variants |
12/19/1996 | WO1996040913A1 A gene encoding a human reduced folate carrier (rfc) and methods for the treatment of methotrexate-resistant, transport-deficient cancer cells |
12/19/1996 | WO1996040912A1 Ob protein compositions and method |
12/19/1996 | WO1996040911A1 Modified steroid hormones for gene therapy and methods for their use |
12/19/1996 | WO1996040910A1 Human growth factors, nucleotide sequence encoding growth factors, and methods of use thereof |
12/19/1996 | WO1996040909A1 Bone stimulating factor |
12/19/1996 | WO1996040908A1 OLIGONUCLEOTIDES SPECIFIC FOR CYTOKINE SIGNAL TRANSDUCER gp130 mRNA |
12/19/1996 | WO1996040907A1 Interleukin-1 receptor intracellular ligand proteins and inhibitors of ligand binding |
12/19/1996 | WO1996040903A1 Macrophage activating factors derived from cloned vitamin d binding protein |
12/19/1996 | WO1996040896A1 Method for identifying alzheimer's disease therapeutics using transgenic animal models |
12/19/1996 | WO1996040895A1 Method for identifying alzheimer's disease therapeutics using transgenic animal models |
12/19/1996 | WO1996040894A1 Treatment of insulin resistance |
12/19/1996 | WO1996040893A1 Nucleic acid and amino acid sequences relating to helicobacter pylori for diagnostics and therapeutics |
12/19/1996 | WO1996040892A1 Tetracycline regulated transcriptional modulators with altered dna binding specificities |
12/19/1996 | WO1996040890A1 Non-naturally occurring targeted lipolytic compounds: synthesis, demonstration of potency, and practical and therapeutic applications |
12/19/1996 | WO1996040885A2 β-SECRETASE, ANTIBODIES TO β-SECRETASE, AND ASSAYS FOR DETECTING β-SECRETASE INHIBITION |
12/19/1996 | WO1996040884A1 Novel filariid nematode cysteine protease proteins, nucleic acid molecules and uses thereof |
12/19/1996 | WO1996040881A1 Fucosyltransferase genes and uses thereof |
12/19/1996 | WO1996040879A1 Dna cassettes for expression of lytic peptides in mammalian cells and transgenic organisms containing same |
12/19/1996 | WO1996040878A1 Monkey monoclonal antibodies specific to human b7.1 and/or b7.2 primatized forms, pharmaceutical compositions |
12/19/1996 | WO1996040871A1 Bioartificial organs comprising open pored foam-like membranes |
12/19/1996 | WO1996040867A1 Recombinant viral nucleic acids |
12/19/1996 | WO1996040864A1 A novel protein, faf1, which potentiates fas-mediated apoptosis and uses thereof |
12/19/1996 | WO1996040829A1 Crosslinkable polypeptide compositions |
12/19/1996 | WO1996040795A1 Antigenic group b streptococcus type ii and type iii polysaccharide fragments having a 2, 5-anhydro-d-mannose terminal structure and conjugate vaccine thereof |
12/19/1996 | WO1996040789A1 THERAPEUTIC COMPOUNDS COMPRISED OF ANTI-Fc RECEPTOR ANTIBODIES |
12/19/1996 | WO1996040788A1 Anti-allergy bispecific molecules |
12/19/1996 | WO1996040787A1 Monoclonal antibody detection of proteins on sperm related to fertility |
12/19/1996 | WO1996040786A1 Lymphocyte chemoattractant factor and uses thereof |
12/19/1996 | WO1996040784A2 Method of solubilizing, purifying, and refolding protein |
12/19/1996 | WO1996040783A1 Separating unmodified hemoglobin from cross-linked hemoglobin |
12/19/1996 | WO1996040782A1 Separation of hemoglobin on hydroxyapatite using hplc |
12/19/1996 | WO1996040781A1 CYCLIC PEPTIDE INHIBITORS OF β1 AND β2 INTEGRIN-MEDIATED ADHESION |